Total bilirubin >= . mg/dL (>  mol/L, SI unit equivalent)
Serum total bilirubin ? . mg/dL ( ?mol/L). In the case of Gilbert's syndrome, or documented liver or pancreatic involvement by lymphoma, serum total bilirubin must be ? . mg/dL ( ?mol/L).
Adequate organ function defined as absolute neutrophil count ?,^/L, absolute lymphocyte count ?/mm^, and platelet count ?,^/mm^. Adequate liver function defined as aspartate aminotransferase and alanine aminotransferase ?. the upper limit of institutional normal, bilirubin ?. mg/dL or  mol/L. Adequate renal function defined as blood urea nitrogen and serum creatinine of ?. mg/dL or  mol/L.
NIH Stage  or higher acute GVHD of the liver (i.e., bilirubin >  mg/dL [SI: >  ?mol/L]) within  days prior to Day 
ALT > x ULN, AST > x ULN, or total bilirubin >  mg/dL [SI: >  ?mol/L] within  days prior to Day 
Serum creatinine level ?. mg/dL ( ?mol/L)
Total bilirubin =< . mg/dL (. mol/L)
Adequate organ function as defined below:  Liver function: a. Total bilirubin < . mg/dL ( mol/L) b. AST and/or ALT < x ULN
Creatinine >  ?mol/L (>  mg/dL) at screening
Serum total bilirubin <. mg/dL ( mol/L)
Renal insufficiency: serum creatinine >  mol/l
Total bilirubin >= . mg/dL (>  mol/L, International System of Units [SI] unit equivalent)
Adequate hepatic function, with serum ALT ? times the upper limit of normal and\n             serum direct bilirubin ?  mg/dL ( mol/L) within  days prior to randomization
Serum creatinine  months to  year: male . mg/dL ( mol/L) female . mg/dL ( mol/L)
Serum creatinine  to <  years: male . mg/dL ( mol/L) female . mg/dL ( mol/L)
Serum creatinine  to <  years: male . mg/dL ( mol/L) female . mg/dL ( mol/L)
Serum creatinine  to < years: male  mg/dL ( mol/L) female  mg/dL ( mol/L)
Serum creatinine  to < years: male . mg/dL ( mol/L) female . mg/dL ( mol/L)
Serum creatinine  to < years: male . mg/dL ( mol/L) female . mg/dL ( mol/L)
Serum creatinine ? years: male . mg/dL ( mol/L) female . mg/dL ( mol/L)
Serum creatinine ? . mg/dL or  mol/L
Subject has creatinine >  mg/dL ( ?mol/L).
Creatinine >  mg/dL ( mol/L) at screening;
Creatinine >  mg/dL ( mol/L), dialysis or prior renal transplant;
total bilirubin > . mg/dl ( mol/L) except in cases of Gilberts Syndrome and documented liver or pancreatic involvement by lymphoma
Serum creatinine < . mg/dL or  ?mol/L
Creatinine >  ?mol/L (>  mg/dL) at screening.
Serum creatinine level > mol/L in case platelet count is > E/L
Bilirubin >=. mg/dL (>  mol/L, International System [SI] unit equivalent)
Adequate renal function as evidenced by serum creatinine ? . mg/dL ( mol/L)
Patients with a serum creatinine >  mg/dL ( mol/L) [Exception: Patients with a serum creatinine >  mg/dL ( mol/L) and being treated with continuous renal replacement therapy (Continuous Veno-Venous Hemodialysis and CVVHemoDiafiltration) or daily hemodialysis will receive the aerosol study drug treatment]
Adequate hepatic function, with serum ALT ? . times the upper limit of normal and serum direct bilirubin ?  mg/dL ( mol/L) within  days prior to randomization
Serum total bilirubin ? . mg/dL ( ?mol/L), except for subjects with Gilbert's syndrome.
